Also in this context, curcumin (or a stable analog) proposed for therapeutic treatment of ovarian cancer (Terlikowska et al., 2014), downregulated AQP3 and reduced cell migration in CaOV3, an effect mediated by inhibition of EGFR signaling (Ji et al., 2008). The gene discussed is AQP3; the disease is ovarian carcinoma.